Skip to main content
. 2012 Nov;53(11):2436–2442. doi: 10.1194/jlr.P026328

Fig. 2.

Fig. 2.

Estimated HRs for major cardiovascular events by atorvastatin dose subgroup. Treatment groups: T/A indicates torcetrapib treatment on background atorvastatin; A indicates atorvastatin background treatment alone.